Allara Health, a virtual care platform for women with chronic hormonal conditions, has secured $26 million in Series B funding led by Index Ventures, with participation from GV (Google Ventures). The round, bringing total funding to $38.5 million, will support nationwide expansion of specialized care delivery.
The company addresses significant gaps in hormonal healthcare, where 1 in 3 women battle chronic conditions like PCOS, endometriosis, and hypothyroidism. Current statistics highlight the need: 70% of PCOS cases go undiagnosed, endometriosis diagnoses take an average of ten years, and 30% of women report having their health concerns dismissed by doctors.
“Allara was built for the tens of millions of women living with complex hormonal and gynecologic conditions across the U.S., myself included,” said founder and CEO Rachel Blank. “After receiving a PCOS diagnosis without sufficient medical support, I realized firsthand the inequities that exist for many of us throughout the healthcare system.”
The company reported significant growth in 2024, expanding its operations to all 50 states and establishing insurance partnerships with major providers including Aetna, Blue Cross Blue Shield, Cigna, Humana, and United Healthcare. Over 75% of patients report feeling more in control of their health within weeks of starting treatment.
Allara’s platform combines medical expertise with lifestyle management and community support, delivered by a team including OB-GYNs, endocrinologists, nurse practitioners, and Registered Dietitians. The company has appointed Dr. Heather Huddleston, director of the UCSF PCOS Clinic, as Chief Medical Officer.
“The challenges that women face in healthcare have been overlooked and underappreciated for too long,” said Martin Mingot, Partner at Index Ventures, who will join Allara’s board. “Allara has created a new way for women to engage with specialty care: personalized treatment delivered at scale by a team of experts who care deeply about their patients.”
